Skip to content
HowShorted

Corbus Pharmaceuticals Holdings, Inc. short interest in 2019

In 2019, Corbus Pharmaceuticals Holdings, Inc.'s disclosed short interest ran from 22.68% of shares outstanding on 15 Jan 2019 to 23.59% on 31 Dec 2019, a change of +0.91 percentage points. The year's high was 26.05% on 15 Jul 2019 and its low 21.81% on 31 Jan 2019, averaging 24.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 41.63 days on 31 Oct 2019. Full history: Corbus Pharmaceuticals Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Corbus Pharmaceuticals Holdings, Inc. in 2019

2019 in figures

Start of year
22.68% (15 Jan 2019)
End of year
23.59% (31 Dec 2019)
Change
+0.91 pp
High
26.05% (15 Jul 2019)
Low
21.81% (31 Jan 2019)
Average
24.58%
Highest days to cover
41.63 (31 Oct 2019)
SEC filings marked
8

Every report in 2019

Corbus Pharmaceuticals Holdings, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201922.68%8.48
31 Jan 201921.81%11.90
15 Feb 201922.66%8.29
28 Feb 201922.83%6.71
15 Mar 201925.06%6.2410-K filed, results (8-K)
29 Mar 201925.40%10.98
15 Apr 201925.29%10.70
30 Apr 201925.19%17.06
15 May 201925.62%14.3610-Q filed, results (8-K)
31 May 201925.06%22.57
14 Jun 201925.41%24.24
28 Jun 201925.30%17.36
15 Jul 201926.05%33.51
31 Jul 201925.11%36.71
15 Aug 201924.06%16.9010-Q filed, results (8-K)
30 Aug 201925.01%29.46
13 Sep 201925.06%27.93
30 Sep 201924.98%32.33
15 Oct 201925.32%33.94
31 Oct 201925.06%41.63
15 Nov 201924.98%14.0010-Q filed, results (8-K)
29 Nov 201924.39%28.40
13 Dec 201923.95%33.11
31 Dec 201923.59%24.99

See also: Corbus Pharmaceuticals Holdings, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.